Treatment of NOD mice with an IGF-I/IGFBP3 complex protects against type 1 diabetes

被引：0
|
作者：
Chen, W [1 ]
Salojin, K [1 ]
Zucker, P [1 ]
Delovitch, TL [1 ]
机构：
[1] John P Robarts Res Inst, London, ON N6G 2V4, Canada
来源：
FASEB JOURNAL | 2002年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1046 / A1046
页数：1
相关论文
共 50 条
  • [41] Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes
    Saukkonen, Tero
    Shojaee-Moradie, Fariba
    Williams, Rachel M.
    Amin, Rakesh
    Yuen, Kevin C.
    Watts, Angie
    Acerini, Carlo L.
    Umpleby, A. Margot
    Dunger, David B.
    DIABETES, 2006, 55 (08) : 2365 - 2370
  • [42] IGF-I at diagnosis and subsequent years in adolescents with type 1 diabetes
    Chisalita, S.
    Ludvigsson, J.
    DIABETOLOGIA, 2017, 60 : S561 - S561
  • [43] Associations between PSA and IGF-I, IGF-II, IGFBP-1, and IGFBP-3 in breast cancer.
    Yu, H
    Levesque, MA
    Khosravi, MJ
    PapanastasiouDiamandis, A
    Clark, GM
    Diamandis, EP
    CLINICAL CHEMISTRY, 1996, 42 (06) : 703 - 703
  • [44] Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy
    Gabriela Ballerini, Maria
    Braslavsky, Debora
    Alejandra Scaglia, Paula
    Keselman, Ana
    Eugenia Rodriguez, Maria
    Martinez, Alicia
    Veronica Freire, Analia
    Mario Domene, Horacio
    Guillermo Jasper, Hector
    Bergada, Ignacio
    Gabriela Ropelato, Maria
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 (05): : 354 - 363
  • [45] Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD mice
    Kodama, K
    Shimada, A
    Funae, O
    Morimoto, J
    Irie, J
    Shigihara, T
    Oikawa, Y
    Tokui, M
    Watanabe, K
    Saruta, T
    AUTOIMMUNITY, 2004, 37 (6-7) : 481 - 487
  • [46] American Diabetes Association annual meeting 1996: Complications, treatment of type I diabetes, and IGF-I
    Bloomgarden, ZT
    DIABETES CARE, 1997, 20 (01) : 111 - 114
  • [47] Prevention of diabetes in non-obese diabetic (NOD) mice by short-term and high-dose IGF-I treatment
    Kaino, Y
    Hirai, H
    Ito, T
    Kida, K
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1998, 11 (02): : 267 - 272
  • [48] INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) PROTECTS NOD MICE FROM INSULITIS AND DIABETES
    BERGEROT, I
    FABIEN, N
    MAGUER, V
    THIVOLET, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 102 (02): : 335 - 340
  • [49] Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3
    Harrela, M
    Koistinen, H
    Kaprio, J
    Lehtovirta, M
    Tuomilehto, J
    Eriksson, J
    Tolvanen, L
    Koskenvuo, M
    Leinonen, P
    Koistinen, R
    Seppala, M
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11): : 2612 - 2615
  • [50] Changes in IGF-I, IGFBP-1 and IGFBP-3 proteolysis in response to acute exercise and insulin infusion
    Nygren, J
    Thorell, A
    Ljungqvist, O
    Brismar, K
    Bang, P
    FASEB JOURNAL, 1999, 13 (04): : A80 - A80
12345